RECRUITING

Effect of Pulsatile Hormone Administration on Insulin Action

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.

Official Title

Effect of Pulsatile Hormone Administration on Insulin Action

Quick Facts

Study Start:2024-03-04
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06216665

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Completion of the Motivate Study (NCT05649176)
  1. * Non-completion of the end-of-study hyperinsulinemic euglycemic clamp test of the Motivate study

Contacts and Locations

Study Contact

Candida J Rebello, Ph.D.
CONTACT
225-763-3159
Candida.Rebello@pbrc.edu
Frank L Greenway, MD
CONTACT
225-763-2578
Frank.Greenway@pbrc.edu

Principal Investigator

Candida Rebello, PhD
PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center

Study Locations (Sites)

Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808
United States

Collaborators and Investigators

Sponsor: Pennington Biomedical Research Center

  • Candida Rebello, PhD, PRINCIPAL_INVESTIGATOR, Pennington Biomedical Research Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-04
Study Completion Date2024-12

Study Record Updates

Study Start Date2024-03-04
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Insulin Sensitivity